However, reliable and robust biomarkers are not yet available for ccRCC.24 Biomarkers predictive of response were not assessed in this study and thus, the effect of PTEN expression on response to sapanisertib in these patients is unknown. The gene discussed is PTEN; the disease is nonpapillary renal cell carcinoma.